Lou Xiao-Qian, Wang Da-Wei, Wang Jun-Feng, Du Bing
Department of Endocrinology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
Department of Emergency Medicine, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
World J Diabetes. 2020 Nov 15;11(11):481-488. doi: 10.4239/wjd.v11.i11.481.
The coronavirus disease 2019 (COVID-19) outbreak that occurred in late 2019 has posed a huge threat to the health of all humans, especially for individuals who already have diabetes mellitus (DM). DM is one of the most serious diseases that affect human health, with high morbidity and rates of complications. Medical scientists worldwide have been working to control blood sugar levels and the complications associated with sugar level alterations, with an aim to reduce the adverse consequences of acute and chronic complications caused by DM. Patients with DM face great challenges during the pandemic owing to not only changes in the allocation of medical resources but also their abnormal autoimmune status, which reduces their resistance to infections. This increases the difficulty in treatment and the risk of mortality. This review presents, from an epidemiological viewpoint, information on the susceptibility of patients with DM to COVID-19 and the related treatment plans and strategies used in this population.
2019年末爆发的2019冠状病毒病（COVID-19）对全人类的健康构成了巨大威胁，尤其是对已经患有糖尿病（DM）的个体。糖尿病是影响人类健康最严重的疾病之一，发病率和并发症发生率都很高。世界各地的医学科学家一直在努力控制血糖水平以及与血糖水平变化相关的并发症，目的是减少糖尿病引起的急慢性并发症的不良后果。糖尿病患者在疫情期间面临巨大挑战，这不仅是由于医疗资源分配的变化，还因为他们异常的自身免疫状态，这降低了他们对感染的抵抗力。这增加了治疗难度和死亡风险。本综述从流行病学角度介绍了糖尿病患者对COVID-19的易感性以及该人群使用的相关治疗方案和策略的信息。
